Amedeo Smart

Free Medical Literature Service

 

Amedeo

Sexually Transmitted Diseases
  Free Subscription

Articles published in
PLoS One
    January 2025
  1. ZHANG Y, Luo L, Du S, Hou D, et al
    Development and validation of the health education demand scale for HPV infected patients based on KANO model.
    PLoS One. 2025;20:e0309630.
    >> Share

  2. METELMANN S, Thompson A, Donten A, Oke S, et al
    A systematic review to identify research gaps in studies modeling MenB vaccinations against Neisseria infections.
    PLoS One. 2025;20:e0316184.
    >> Share

  3. TAKAHASHI Y, Sasamori Y, Higuchi R, Kaku A, et al
    Effects of different educational interventions on cervical cancer knowledge and human papillomavirus vaccination uptake among young women in Japan: Preliminary results of a cluster randomized controlled trial.
    PLoS One. 2025;20:e0311588.
    >> Share

  4. RAHMAN MM, Masum MHU, Parvin R, Das SC, et al
    Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation.
    PLoS One. 2025;20:e0313559.
    >> Share

  5. SHAH SA, Zubair M, Soomro A, Sheikh R, et al
    Analysis of seroprevalence and risk factors for syphilis and HIV among female sex workers and transgender individuals in different cities of Sindh, Pakistan.
    PLoS One. 2025;20:e0312683.
    >> Share

  6. CARROLL JA, Mullens AB, Warzywoda S, Baker PRA, et al
    Acceptability and feasibility of pre-exposure prophylaxis for bacterial STIs: a systematic review.
    PLoS One. 2025;20:e0317669.
    >> Share

  7. CORTEZ AL, Avelino-Silva VI, Labella Henriques B, Vernal S, et al
    Syphilis seroprevalence and risk factors among first-time blood donors in Brazil: A comprehensive repeated cross-sectional analysis spanning a decade.
    PLoS One. 2025;20:e0315933.
    >> Share

  8. ASIIMWE S, Bagenda FN, Mugisa T
    Factors associated with uptake of human papilloma virus vaccine among adolescent girls: A cross sectional survey on insights into HPV Infection Prevention in Kabarole District, Western Uganda.
    PLoS One. 2025;20:e0306960.
    >> Share

  9. GARCIA LUNA JA, Romero-Rosas N, Silva Pena SA, Oviedo Sarmiento OJ, et al
    Correction: Diagnostic performance of two rapid tests for syphilis screening in people living with HIV in Cali, Colombia.
    PLoS One. 2025;20:e0320868.
    >> Share

  10. BURKE-GARCIA A, Cutroneo E, Afanaseva D, Madden K, et al
    Findings from a qualitative analysis: Social media influencers of color as trusted messengers of HPV vaccination messages.
    PLoS One. 2025;20:e0319160.
    >> Share

  11. MAFI S, Theuillon F, Meyer S, Woillard JB, et al
    Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples.
    PLoS One. 2025;20:e0320978.
    >> Share

  12. DE BRITO KC, da Silva MFCR, Cardoso CW, Silva LK, et al
    A randomized, controlled trial of a web-based tailored intervention to increase human papillomavirus vaccination among people living with HIV/AIDS.
    PLoS One. 2025;20:e0319646.
    >> Share

  13. ABATE A, Munshea A, Nibret E, Bezabih B, et al
    Evaluation of Onco E6 point of care rapid diagnostic test for human papilloma virus in Bahir Dar, Amhara Regional State, Ethiopia.
    PLoS One. 2025;20:e0321076.
    >> Share

  14. RAPAJIC-MORAN I, Filipic B, Rajkovic D, Rakic M, et al
    Strengthening the role of community pharmacy in HPV vaccination roll-out in Serbia at national and local levels: A pharmacy-based education approach.
    PLoS One. 2025;20:e0322584.
    >> Share

  15. ZHANG M, Huang Y, Zhang S, Peng S, et al
    The epidemiology and risk factors of anal and oropharyngeal human papillomavirus (HPV) in males living with human immunodeficiency virus (HIV): A protocol for systematic review and meta-analysis.
    PLoS One. 2025;20:e0320899.
    >> Share

  16. GUAN J, Feng J, Zhu L, Ding J, et al
    Active screening significantly improves detection of chlamydia in women's health clinics in Shaoxing, China.
    PLoS One. 2025;20:e0321492.
    >> Share

  17. DE VOS L, Mdingi MMM, Gigi RMS, Gebengu A, et al
    Spectrum of sexual partner types among adults screened for sexually transmitted infections in the Eastern Cape, South Africa.
    PLoS One. 2025;20:e0323414.
    >> Share

  18. MANTINA NM, Smith J, Miiro FN, Magrath PA, et al
    Perspectives of HPV vaccine decision-making among young adults: A qualitative systematic review and evidence synthesis.
    PLoS One. 2025;20:e0321448.
    >> Share

  19. OYEDEJI O, North C, Kintziger KW, Ehrlich S, et al
    Understanding young adults' perceptions regarding human papillomavirus vaccination: A qualitative study.
    PLoS One. 2025;20:e0323063.
    >> Share

  20. NOREEN K, Khalid SN, Javaid M, Khan SA, et al
    Public Health Implications of Introducing Human Papillomavirus (HPV) Vaccination in Pakistan: A protocol for a mixed-method study to explore community perceptions and health system preparedness.
    PLoS One. 2025;20:e0323826.
    >> Share

  21. ZARGARAN H, Ghaemi A, Shenagari M, Samadi M, et al
    Boosting immune response against cervical cancer: A combined approach using oncolytic virus and targeted therapies.
    PLoS One. 2025;20:e0312979.
    >> Share

  22. ASSOAH E, Yar DD, Amissah-Reynolds PK, Balali GI, et al
    Co-infections and risk factors of Toxoplasma gondii infection among pregnant women in Ghana: A facility-based cross-sectional study.
    PLoS One. 2025;20:e0324950.
    >> Share

  23. ABDELSATTAR AS, Abutaleb NS, Seleem MN
    A novel peptide mimetic, brilacidin, for combating multidrug-resistant Neisseria gonorrhoeae.
    PLoS One. 2025;20:e0325722.
    >> Share

  24. HAO S, Velasquez EE, Pearson WS, Hoover KW, et al
    Primary care screening for sexually transmitted infections in the United States from 2019 to 2021.
    PLoS One. 2025;20:e0325097.
    >> Share

  25. ENYEW EB, Kasaye MD, Kebede SD, Feyisa MS, et al
    Human Papillomavirus Vaccination uptake and associated factors among schools girls aged between 9-14 years in Ethiopia: Performance Monitoring for Action (PMA-ET) 2023, multilevel analysis.
    PLoS One. 2025;20:e0325557.
    >> Share

  26. YANG Y, Lu Y, Li Y, Qin C, et al
    Factors affecting caregivers' HPV vaccination decisions for adolescent girls: A secondary analysis of a Chinese RCT.
    PLoS One. 2025;20:e0324260.
    >> Share

  27. PATURY P, Russomano FB, Moreira MAM, Kappaun NRC, et al
    Associations between genetic HPV 16 diversity and cervical cancer prognosis.
    PLoS One. 2025;20:e0308895.
    >> Share

  28. PALENA G, Stilo I, Sorrentino M, Fiorilla C, et al
    Organizational barriers in HPV vaccination uptake: A cross-sectional study among health sciences students.
    PLoS One. 2025;20:e0326694.
    >> Share

  29. HASAN MM, Islam MH
    Herd immunity and prevention in HPV transmission with exogenous reinfection.
    PLoS One. 2025;20:e0327233.
    >> Share

  30. SILVA FILHO GFD, Milhomem AB, Diniz E Silva BV, Santos KCD, et al
    Taking the opportunity of COVID testing to screen vulnerable populations for hepatitis B, hepatitis C, syphilis, and human immunodeficiency virus in Central Brazil.
    PLoS One. 2025;20:e0325859.
    >> Share

  31. AGHA S, Nsofor I
    HPV vaccine uptake among adolescent girls in Nigeria: The complex role of caregivers' education.
    PLoS One. 2025;20:e0325684.
    >> Share

  32. PEREZ-ARELLANO JL, Hernandez Betancor A, Sanz Pelaez O, Curbelo J, et al
    Treponema pallidum infection in asymptomatic persons: A puzzling scenario in the Canary Islands (Spain) (2001-2020).
    PLoS One. 2025;20:e0325073.
    >> Share

  33. NJAU AF, Robert M, Rwebembera A, Kisendi R, et al
    Prevalence and associated factors for HIV, HBV and syphilis coinfections among pregnant women attending antenatal care in Tanzania.
    PLoS One. 2025;20:e0329068.
    >> Share

  34. MREMA A, Ngoma M, Lugina EL, Kahakwa A, et al
    Genotype distribution of human papillomavirus among women with cervical cancer stratified by HIV status in Tanzania.
    PLoS One. 2025;20:e0322311.
    >> Share

  35. JACOBS KR, Ardizzone CM, Banerjee A, Toh E, et al
    Isolation and characterization of a Chlamydia muridarum tc0237 mutant from a genetic screen that is attenuated in epithelial cells.
    PLoS One. 2025;20:e0329637.
    >> Share

  36. ALEXIOU ZW, Hoenderboom BM, Hoebe CJPA, Scholte I, et al
    Prevalence and risk factors for Chlamydia trachomatis seropositivity and seropersistence among women: A prospective cohort study.
    PLoS One. 2025;20:e0328449.
    >> Share

  37. ILYASOVA AA, Queen TL, Gilkey M, Fogel BN, et al
    Use of presumptive recommendations and other strategies to encourage HPV vaccine uptake: Results from a national survey of primary care health professionals.
    PLoS One. 2025;20:e0327872.
    >> Share

  38. JIN Y, Lu R, Wang M, Xu Z, et al
    Analysis of blood screening strategies and their efficacy among voluntary blood donors in a region of East China.
    PLoS One. 2025;20:e0331027.
    >> Share

  39. LEONHARD AK, Badre-Esfahani SK, Larsen MB, Petersen LK, et al
    "Two shots for life. HPV-vaccination at your school". Co-creation of a complex intervention to reduce ethnic inequity in childhood HPV-vaccination in Denmark.
    PLoS One. 2025;20:e0323870.
    >> Share

  40. KASSA B, Mohammed A, Wassie GT
    Parents' acceptance of human papilloma virus vaccination for their daughters in adet town, North Gojjam zone, Northwest Ethiopia: A mixed method study.
    PLoS One. 2025;20:e0330911.
    >> Share

  41. DEN'O ZD, Paulos W, Markos D, Oche WO, et al
    Human papilloma virus vaccination uptake and associated factors among adolescent girls in Merab Abaya district, Gamo zone, Southern Ethiopia: Mixed methods.
    PLoS One. 2025;20:e0330760.
    >> Share

  42. STRBAC M, Ukropina S, Nikolic N, Masic K, et al
    Impact of health promotion strategies on HPV vaccination uptake: A descriptive epidemiological study (2019-2024).
    PLoS One. 2025;20:e0331592.
    >> Share

  43. WYNN A, Harris D, Modest A, Reyes MF, et al
    Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana.
    PLoS One. 2025;20:e0328803.
    >> Share

  44. PICHAILUCK C, Sakunborrirak P, Kittiyaowamarn R, Neungton C, et al
    Prevalence of common bacterial STI pathogens and the microscopic diagnostic approach to abnormal vaginal discharge in a tertiary care hospital in Bangkok, Thailand.
    PLoS One. 2025;20:e0331668.
    >> Share

  45. BASHORUN AO, Kotei L, Jallow AF, Jawla O, et al
    Human papillomavirus, sexually transmitted infections, and antimicrobial resistance in West Africa: Estimating population burden and understanding exposures to accelerate vaccine impact and drive new interventions: The PHASE survey protocol.
    PLoS One. 2025;20:e0332842.
    >> Share

    January 2024
  46. DOS SANTOS LM, Vieira MRMDS, Vieira RC, Silva LBDL, et al
    Prevalence and circulant genotypes of Chlamydia trachomatis in university women from cities in the Brazilian Amazon.
    PLoS One. 2024;19:e0287119.
    >> Share

  47. SETIAWAN D, Nurulita NA, Khoirunnisa SM, Postma MJ, et al
    The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women.
    PLoS One. 2024;19:e0290808.
    >> Share

  48. GUILLAUME D, Waheed DE, Schleiff M, Muralidharan KK, et al
    Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
    PLoS One. 2024;19:e0291990.
    >> Share

  49. MBOUMBA BOUASSA RS, Avala Ntsigouaye J, Lemba Tsimba PC, Nodjikouambaye ZA, et al
    Genetic diversity of HPV35 in Chad and the Central African Republic, two landlocked countries of Central Africa: A cross-sectional study.
    PLoS One. 2024;19:e0297054.
    >> Share

  50. SARMIENTO-MEDINA MI, de Amaya MP, Villamizar-Gomez L, Gonzalez-Coba AC, et al
    High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    PLoS One. 2024;19:e0297579.
    >> Share

  51. KANG SW, Kang OJ, Lee JY, Kim H, et al
    Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
    PLoS One. 2024;19:e0298815.
    >> Share

  52. YAO B, Peng J, Song W, Yang L, et al
    Real-world effectiveness of cytology and HPV-based screening strategy in cervical cancer screening: A cross-sectional population-based study in Chengdu, China.
    PLoS One. 2024;19:e0299651.
    >> Share

  53. CAROZZI FM, Royder Yanez R, Paganini I, Sani C, et al
    Cervical cancer prevention: Feasibility of self-sampling and HPV testing in rural and urban areas of Bolivia: An observational study.
    PLoS One. 2024;19:e0292605.
    >> Share

  54. LIN Y, Long Y, He J, Yi Q, et al
    The residual rate of HPV and the recurrence rate of CIN after LEEP with negative margins: A meta-analysis.
    PLoS One. 2024;19:e0298520.
    >> Share

  55. MIRZADEH P, Oye-Somefun A, Ardern CI, Buick CJ, et al
    Association between human papillomaviruses, metabolic syndrome, and all-cause death; analysis of the U.S. NHANES 2003-2004 to 2015-2016.
    PLoS One. 2024;19:e0299479.
    >> Share

  56. BELACHEW EB, Desta AF, Mulu A, Deneke DB, et al
    High rate of high-risk human papillomavirus among benign and breast cancer patients in Ethiopia.
    PLoS One. 2024;19:e0298583.
    >> Share

  57. HAMILL MM, Onzia A, Parkes-Ratanshi RM, Kyambadde P, et al
    Antibiotic overuse, poor antimicrobial stewardship, and low specificity of syndromic case management in a cross section of men with urethral discharge syndrome in Kampala, Uganda.
    PLoS One. 2024;19:e0290574.
    >> Share

  58. KOMORI A, Mori H, Xie W, Valenti S, et al
    Rapid resurgence of syphilis in Japan after the COVID-19 pandemic: A descriptive study.
    PLoS One. 2024;19:e0298288.
    >> Share

  59. CECCARANI C, Gaspari V, Morselli S, Djusse ME, et al
    Chlamydia trachomatis and Neisseria gonorrhoeae rectal infections: Interplay between rectal microbiome, HPV infection and Torquetenovirus.
    PLoS One. 2024;19:e0301873.
    >> Share

  60. OOMMEN AM, Isaac R, Paul B, Weller D, et al
    Strategies for primary HPV test-based cervical cancer screening programme in resource-limited settings in India: Results from a quasi-experimental pragmatic implementation trial.
    PLoS One. 2024;19:e0301385.
    >> Share

  61. DU-THANH A, Foulongne V, Dereure O, Eloit M, et al
    A quantitative assay for the assessment of cutaneous human papillomaviruses and polyomaviruses over time: A proof-of-concept in two patients with atopic dermatitis and psoriasis.
    PLoS One. 2024;19:e0297907.
    >> Share

  62. AMJAD HAFEEEZ A, Cavalcanti Bezerra K, Jimoh Z, Seal FB, et al
    Scoping review of hearing loss attributed to congenital syphilis.
    PLoS One. 2024;19:e0302452.
    >> Share

  63. ZEBER-LUBECKA N, Kulecka M, Dabrowska M, Baginska-Drabiuk K, et al
    Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection.
    PLoS One. 2024;19:e0302270.
    >> Share

  64. CHEMAITELLY H, Finan RR, Racoubian E, Aimagambetova G, et al
    Estimates of the incidence, prevalence, and factors associated with common sexually transmitted infections among Lebanese women.
    PLoS One. 2024;19:e0301231.
    >> Share

  65. MUMBA C, Muhimbe Z, Mapulanga V, Kawimbe M, et al
    The effects of HIV and oncogenic human papillomavirus on the tumor immune microenvironment of penile squamous cell carcinoma.
    PLoS One. 2024;19:e0300729.
    >> Share

  66. ANWAR N, Chundriger Q, Awan S, Moatter T, et al
    Prevalence of high-risk human papillomavirus in oral squamous cell carcinoma with or without chewing habits.
    PLoS One. 2024;19:e0300354.
    >> Share

  67. ZULU EM, Herlihy JM, Duffy CR, Mwananyanda L, et al
    Single-test syphilis serology: A case of not seeing the forest for the trees.
    PLoS One. 2024;19:e0303253.
    >> Share

  68. BOSAK J, Mikalova L, Hrala M, Pospisilova P, et al
    Treponema pallidum subsp. pallidum strains DAL-1 and Philadelphia 1 differ in generation times in vitro as well as during experimental rabbit infection.
    PLoS One. 2024;19:e0304033.
    >> Share

  69. BOAITEY YA, Owusu-Ofori A, Anyogu A, Aghakhanian F, et al
    Prevalence of yaws and syphilis in the Ashanti region of Ghana and occurrence of H. ducreyi, herpes simplex virus 1 and herpes simplex virus 2 in skin lesions associated with treponematoses.
    PLoS One. 2024;19:e0295088.
    >> Share

  70. LOPEZ-CODONY V, de Andres-Pablo A, Ferrando-Diez A, Fernandez-Montoli ME, et al
    Assessing the reduction of viral infectivity in HPV16/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): Study protocol.
    PLoS One. 2024;19:e0304080.
    >> Share

  71. ORSER L, Tran V, O'Byrne P, Kroch A, et al
    Testing for extragenital Neisseria gonorrhoeae and Chlamydia trachomatis: At-home pharyngeal and rectal self-swabs are non-inferior to those completed in healthcare settings.
    PLoS One. 2024;19:e0302785.
    >> Share

  72. GEDEFIE A, Debash H, Asmamaw S, Getaneh FB, et al
    Epidemiology of an overlapping and parallel infection of Sexually Transmitted Infections among pregnant women in North-east Ethiopia: Its implication for prevention of mother to child transmission.
    PLoS One. 2024;19:e0300149.
    >> Share

  73. LIANG D, Zhang Q, Li W, Lin Y, et al
    Analysis of urinary tobacco-specific nitrosamine 4- (methylnitrosamino)1-(3-pyridyl)-1- butanol (NNAL) and HPV infection in American women: National health and nutrition examination survey.
    PLoS One. 2024;19:e0304499.
    >> Share

  74. SABIN L, Haghparast-Bidgoli H, Miller F, Saville N, et al
    A systematic review of barriers and facilitators to antenatal screening for HIV, syphilis or hepatitis B in Asia: Perspectives of pregnant women, their relatives and health care providers.
    PLoS One. 2024;19:e0300581.
    >> Share

  75. CHOMEAN S, Puttaruk P, Khamsophar P, Fukpo W, et al
    Evaluation of rapid diagnostic test kits for detection of Treponema pallidum antibody.
    PLoS One. 2024;19:e0303477.
    >> Share

  76. MUSONDA P, Halwiindi H, Kaonga P, Ngoma-Hazemba A, et al
    HIV, syphilis and sexual-risk behaviours' prevalence among in-and out-of-school adolescent girls and young women in Zambia: A cross-sectional survey study.
    PLoS One. 2024;19:e0294545.
    >> Share

  77. JONES AV, Manasyan A, Xue Y, Kapesa H, et al
    Benzathine penicillin G stockouts and other barriers to documented syphilis treatment in pregnancy in Zambia.
    PLoS One. 2024;19:e0304576.
    >> Share

  78. DEN BOOGERT EM, van Aar F, Heijne JCM
    Investigating possibilities for surveillance of long term chlamydia complications in the Netherlands: A qualitative study.
    PLoS One. 2024;19:e0305279.
    >> Share

  79. BANDEIRA IC, Comerlato J, Bessel M, Fernandes BV, et al
    Comparative evaluation of HPV genotyping: A study on the performance concordance between Anyplex II HPV28 detection and Linear Array genotyping tests in nationwide studies in Brazil.
    PLoS One. 2024;19:e0305122.
    >> Share

  80. CERVANTES PW, Segelke BW, Lau EY, Robinson BV, et al
    Sequence, structure prediction, and epitope analysis of the polymorphic membrane protein family in Chlamydia trachomatis.
    PLoS One. 2024;19:e0304525.
    >> Share

  81. MUHAMMAD I, Khalifa EH, Salih MM, Ullah W, et al
    Analysis of molecular subtypes and antibiotic resistance in Treponema pallidum isolates from blood donors in Khyber Pakhtunkhwa, Pakistan.
    PLoS One. 2024;19:e0305720.
    >> Share

  82. COSTA IB, Pimenta IDSF, Aiquoc KM, Oliveira AGRDC, et al
    Congenital syphilis, syphilis in pregnancy and prenatal care in Brazil: An ecological study.
    PLoS One. 2024;19:e0306120.
    >> Share

  83. NONBOE MH, Napolitano GM, Kann C, Andersen B, et al
    Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study.
    PLoS One. 2024;19:e0306044.
    >> Share

  84. PEDROSA NL, Pinheiro PM, Filho FWBH, de Araujo WN, et al
    Incidence and risk factors associated with acquired syphilis in HIV pre-exposure prophylaxis users.
    PLoS One. 2024;19:e0303320.
    >> Share

  85. TONGTOYAI J, Cherdtrakulkiat T, Girdthep N, Masciotra S, et al
    Data quality assessment of the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), Thailand, 2015-2021.
    PLoS One. 2024;19:e0305296.
    >> Share

  86. DE CARVALHO RR, Carvalho F, Oliveira EB, Souza da Silva R, et al
    Doubts about the diagnosis and treatment of syphilis in pregnancy among primary care professionals in a telehealth service.
    PLoS One. 2024;19:e0306192.
    >> Share

  87. JIN S, Lin F, Yang L, Zhang Q, et al
    Association between dietary folate intake and HPV infection: NHANES 2005-2016.
    PLoS One. 2024;19:e0306636.
    >> Share

  88. SALAZAR JC, Vargas-Cely F, Garcia-Luna JA, Ramirez LG, et al
    Treponema pallidum genetic diversity and its implications for targeted vaccine development: A cross-sectional study of early syphilis cases in Southwestern Colombia.
    PLoS One. 2024;19:e0307600.
    >> Share

  89. MAUFFREY F, Poncet F, Jacot D, Greub G, et al
    Impact of mutations in the mtrR, rpdlVD and rrl genes on azithromycin resistance in Neisseria gonorrhoeae.
    PLoS One. 2024;19:e0306695.
    >> Share

  90. BAUDE J, Guigou C, Thibouw D, Vulquin N, et al
    Definitive radio(chemo)therapy versus upfront surgery in the treatment of HPV-related localized or locally advanced oropharyngeal squamous cell carcinoma.
    PLoS One. 2024;19:e0307658.
    >> Share

  91. BALQIS-ALI NZ, Anis-Syakira J, Fun WH, Mohd Said Z, et al
    Achieving cervical cancer elimination: The simulated impacts of HPV vaccination and transitioning from liquid-based cytology to HPV-based screening test.
    PLoS One. 2024;19:e0307880.
    >> Share

  92. SHI Y, Zhang J, Wang Z, Shan F, et al
    The association between alcohol consumption and herpes simplex virus type 2: A cross-sectional study from national health and nutrition examination survey 2009-2016.
    PLoS One. 2024;19:e0307702.
    >> Share

  93. NAKIBUUKA V, Muddu M, Kraehenbuhl JP, Birungi C, et al
    Uptake of human papilloma virus vaccination among adolescent girls living with HIV in Uganda: A mixed methods study.
    PLoS One. 2024;19:e0300155.
    >> Share

  94. ANTENEH DE, Taye EB, Seyoum AT, Abuhay AE, et al
    Seroprevalence of HIV, HBV, and syphilis co-infections and associated factors among pregnant women attending antenatal care in Amhara regional state, northern Ethiopia: A hospital-based cross-sectional study.
    PLoS One. 2024;19:e0308634.
    >> Share

  95. BRAZ PAULI F, Junior VS, Mesquita RW, Welter Wendt G, et al
    Gestational syphilis in a tertiary health service in Parana, Brazil: A case-control study.
    PLoS One. 2024;19:e0305525.
    >> Share

  96. HARIPRASAD R, Bagepally BS, Kumar S, Pradhan S, et al
    Cost-utility analysis of primary HPV testing through home-based self-sampling in comparison to visual inspection using acetic acid for cervical cancer screening in East district, Sikkim, India, 2023.
    PLoS One. 2024;19:e0300556.
    >> Share

  97. POSPISILOVA P, Cejkova D, Bursikova P, Fedrova P, et al
    The hare syphilis agent is related to, but distinct from, the treponeme causing rabbit syphilis.
    PLoS One. 2024;19:e0307196.
    >> Share

  98. MANGALA C, Maulot-Bangola D, Moutsinga A, Okolongo-Mayani SC, et al
    Prevalence and factors associated with transfusion-transmissible infections (HIV, HBV, HCV and Syphilis) among blood donors in Gabon: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0307101.
    >> Share

  99. KISA S, Kisa A
    Religious beliefs and practices toward HPV vaccine acceptance in Islamic countries: A scoping review.
    PLoS One. 2024;19:e0309597.
    >> Share

  100. SALEEM MU, Farman M, Nisar KS, Ahmad A, et al
    Investigation and application of a classical piecewise hybrid with a fractional derivative for the epidemic model: Dynamical transmission and modeling.
    PLoS One. 2024;19:e0307732.
    >> Share

  101. GOMES FC, Galhardo DDR, Navegante ACG, Santos GSD, et al
    Bioinformatics analysis to identify the relationship between human papillomavirus-associated cervical cancer, toll-like receptors and exomes: A genetic epidemiology study.
    PLoS One. 2024;19:e0305760.
    >> Share

  102. SINGOGO E, Hartney T, Bourdin S, Chagomerana M, et al
    Use of routinely collected blood donation data for expanded HIV and Syphilis surveillance in Blantyre district, Malawi.
    PLoS One. 2024;19:e0300647.
    >> Share

  103. DA CUNHA JA, Marques Dos Santos M, Costa de Lima K
    Acquired syphilis in older people in Brazil from 2010-2020.
    PLoS One. 2024;19:e0296481.
    >> Share

  104. MAUEIA C, Murahwa A, Manjate A, Sacarlal J, et al
    The relationship between selected sexually transmitted pathogens, HPV and HIV infection status in women presenting with gynaecological symptoms in Maputo City, Mozambique.
    PLoS One. 2024;19:e0307781.
    >> Share

  105. GUURE C, Puplampu AE, Dery S, Abu-Ba'are GR, et al
    Syphilis among HIV-positive men who have sex with men in Ghana: The 2023 biobehavioral survey.
    PLoS One. 2024;19:e0310909.
    >> Share

  106. FLOOD T, McLaughlin DM, Wilson DI, Hughes CM, et al
    An exploration of teacher and school-based nurse perceptions of current HPV education offered to students 15-16 years old in post-primary schools in Northern Ireland, UK.
    PLoS One. 2024;19:e0311651.
    >> Share

  107. BAI C, Wang R, Yang Q, Hao J, et al
    Design and antiviral assessment of a panel of fusion proteins targeting human papillomavirus type 16.
    PLoS One. 2024;19:e0311137.
    >> Share

  108. LEE AA, Skyles TJ, Jensen JL, Ord B, et al
    Effects of religion, politics and distance to providers on HPV vaccine attitudes and intentions of parents in rural Utah.
    PLoS One. 2024;19:e0312549.
    >> Share

  109. SULTANOV M, Koot JAR, de Bock GH, Greuter MJW, et al
    High-risk human papillomavirus testing for cervical cancer screening in Uganda: Considering potential harms and benefits in a low-resource setting.
    PLoS One. 2024;19:e0312295.
    >> Share

  110. AREVALOS A, Valenzuela A, Mongelos P, Barrios H, et al
    Genital infections in high-risk human papillomavirus positive Paraguayan women aged 30-64 with and without cervical lesions.
    PLoS One. 2024;19:e0312947.
    >> Share

  111. ATIF M, Zafar H, Wahab AT, Choudhary MI, et al
    Drug repurposing against fucosyltransferase-2 via docking, STD-NMR, and molecular dynamic simulation studies.
    PLoS One. 2024;19:e0308517.
    >> Share

  112. OYEDEJI O, Kintziger KW, Springer CM, Ehrlich S, et al
    Examining HPV vaccination behavior among young adults: Insights from applying the Health Belief Model.
    PLoS One. 2024;19:e0312700.
    >> Share

  113. WANG Y, Suchland R, Hua A, Carrell S, et al
    Development of a lambda Red based system for gene deletion in Chlamydia.
    PLoS One. 2024;19:e0311630.
    >> Share

  114. PLISKO O, Zodzika J, Jermakova I, Pcolkina K, et al
    Prediction of high-grade cervical precancerous abnormalities: The role of personal factors, vaginal microflora, sexually transmitted infections, and high-risk human papillomavirus.
    PLoS One. 2024;19:e0313004.
    >> Share

  115. HAWLADER MDH, Eva FN, Khan MAS, Islam T, et al
    Acceptance of Human Papillomavirus (HPV) vaccine among the parents of eligible daughters (9-15 years) in Bangladesh: A nationwide study using Health Belief Model.
    PLoS One. 2024;19:e0310779.
    >> Share

  116. DANIELS V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, et al
    Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in low/middle-income countries: An analysis of Indonesia.
    PLoS One. 2024;19:e0310591.
    >> Share

  117. ANNI NS, Rehman N, Nyambi A, Musiwa A, et al
    Knowledge, attitudes, and practices towards Human Papilloma Virus and uptake of HPV vaccine: A protocol for a systematic review.
    PLoS One. 2024;19:e0313887.
    >> Share

  118. CRAMEZ C, Lafont M, Boumahni B, Boukerrou M, et al
    Fetal and neonatal outcomes in syphilis infected pregnant women in Reunion Island: An observational retrospective multicentric study.
    PLoS One. 2024;19:e0309828.
    >> Share

  119. EHSASATVATAN M, Baghban Kohnehrouz B
    Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus types.
    PLoS One. 2024;19:e0311351.
    >> Share

  120. CHEN CJ, Kimble B, Van Aggelen A, Fischer S, et al
    Preliminary analyses of tryptophan, kynurenine, and the kynurenine: Tryptophan ratio in plasma, as potential biomarkers for systemic chlamydial infections in koalas.
    PLoS One. 2024;19:e0314945.
    >> Share

  121. CHAKRABORTY S, Nessa A, Ferdous NE, Rahman MM, et al
    Prevalence and genotypic distribution of high-risk human papillomavirus (HPV) among ever-married women in coastal regions of Bangladesh.
    PLoS One. 2024;19:e0313396.
    >> Share

  122. ROSSETTI E, Vujadinovic M, van Huizen E, Tolboom J, et al
    A replication-incompetent adenoviral vector encoding for HSV-2 gD2 is immunogenic and protective against HSV-2 intravaginal challenge in mice.
    PLoS One. 2024;19:e0310250.
    >> Share

  123. HONGJAISEE S, Khamduang W, Kham-Kjing N, Ngo-Giang-Huong N, et al
    Seroprevalence and associated factors of HIV, syphilis, hepatitis B, and hepatitis C infections among sex workers in Chiangmai, Thailand during easing of COVID-19 lockdown measures.
    PLoS One. 2024;19:e0316668.
    >> Share

  124. CAO Q, Hou Y, Wang C, Yin J, et al
    Effect of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0312128.
    >> Share

  125. CHENG SH, Yang YC, Chen CP, Hsieh HT, et al
    Oncogenic human papillomavirus and anal microbiota in men who have sex with men and are living with HIV in Northern Taiwan.
    PLoS One. 2024;19:e0304045.
    >> Share

  126. BHENGU P, Ndwandwe D, Cooper S, Katoto PDMC, et al
    Behavioural and social drivers of human papillomavirus vaccination in eThekwini District of KwaZulu-Natal Province, South Africa.
    PLoS One. 2024;19:e0311509.
    >> Share

  127. KIRAGGA AN, Onzia A, Nakate V, Bagaya I, et al
    Community pharmacies: Key players in point-of-care diagnostics for STI screening in Africa.
    PLoS One. 2024;19:e0315191.
    >> Share

    January 2023
  128. LEE RH, Roy R, Li H, Hechmer A, et al
    Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts.
    PLoS One. 2023;18:e0282177.
    >> Share

  129. RODRIGUEZ NM, Brennan LP, Claure L, Balian LN, et al
    Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
    PLoS One. 2023;18:e0282853.
    >> Share

  130. GARCIA LUNA JA, Romero-Rosas N, Silva Pena SA, Oviedo Sarmiento OJ, et al
    Diagnostic performance of two rapid tests for syphilis screening in people living with HIV in Cali, Colombia.
    PLoS One. 2023;18:e0282492.
    >> Share

  131. BOGERS S, Schim van der Loeff M, Boyd A, van Dijk N, et al
    Improving provider-initiated testing for HIV and other STI in the primary care setting in Amsterdam, the Netherlands: Results from a multifaceted, educational intervention programme.
    PLoS One. 2023;18:e0282607.
    >> Share

  132. EDMONDSON DG, De Lay BD, Hanson BM, Kowis LE, et al
    Clonal isolates of Treponema pallidum subsp. pallidum Nichols provide evidence for the occurrence of microevolution during experimental rabbit infection and in vitro culture.
    PLoS One. 2023;18:e0281187.
    >> Share

  133. BHATTA M, Majumdar A, Ghosh U, Ghosh P, et al
    Sexually transmitted infections among key populations in India: A protocol for systematic review.
    PLoS One. 2023;18:e0279048.
    >> Share

  134. LUGO LZA, Puga MAM, Jacob CMB, Padovani CTJ, et al
    Cytokine profiling of samples positive for Chlamydia trachomatis and Human papillomavirus.
    PLoS One. 2023;18:e0279390.
    >> Share

  135. CHOI J, Markham C, Tami-Maury I, Kim S, et al
    Maternal perceptions of vaccinating boys against human papillomavirus (HPV) in Seoul, South Korea: A descriptive exploratory qualitative study.
    PLoS One. 2023;18:e0282811.
    >> Share

  136. GIBSON-HELM M, Slater T, MacDonald EJ, Stevenson K, et al
    Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
    PLoS One. 2023;18:e0280643.
    >> Share

  137. SMITH JS, Vaz OM, Gaber CE, Des Marais AC, et al
    Recruitment strategies and HPV self-collection return rates for under-screened women for cervical cancer prevention.
    PLoS One. 2023;18:e0280638.
    >> Share

  138. SHIN HI, Cho KJ, Kim MS, Joo YH, et al
    Predictive factors of distant metastasis in surgically treated HPV-positive tonsil cancer.
    PLoS One. 2023;18:e0283368.
    >> Share

  139. ZHU W, Cardenas-Alvarez MX, Tomberg J, Little MB, et al
    Commensal Neisseria species share immune suppressive mechanisms with Neisseria gonorrhoeae.
    PLoS One. 2023;18:e0284062.
    >> Share

  140. BOBADILLA ML, Villagra V, Ortiz V, Deluca G, et al
    High prevalence and co-infection of high-risk Human Papillomavirus genotypes among unvaccinated young women from Paraguay.
    PLoS One. 2023;18:e0283542.
    >> Share

  141. WEATHERLY M, Trivedi A, Chembrolu R, Gupta S, et al
    Maternal infections in pregnancy and the risk of sudden unexpected infant death in the offspring in the U.S., 2011-2015.
    PLoS One. 2023;18:e0284614.
    >> Share

  142. MITI S, Shato T, Asante C, Baumann A, et al
    Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study.
    PLoS One. 2023;18:e0285031.
    >> Share

  143. BRAUTIGAM CA, Deka RK, Tso SC, Liu WZ, et al
    Biophysical and biochemical studies support TP0094 as a phosphotransacetylase in an acetogenic energy-conservation pathway in Treponema pallidum.
    PLoS One. 2023;18:e0283952.
    >> Share

  144. TEIXEIRA IV, da Silva Leite MT, de Morais Melo FL, da Silva Rocha E, et al
    Predicting congenital syphilis cases: A performance evaluation of different machine learning models.
    PLoS One. 2023;18:e0276150.
    >> Share

  145. MWENDA V, Bor JP, Nyangasi M, Njeru J, et al
    Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
    PLoS One. 2023;18:e0286202.
    >> Share

  146. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
    PLoS One. 2023;18:e0286909.
    >> Share

  147. MONTEIRO IP, Azzi CFG, Bilibio JP, Monteiro PS, et al
    Prevalence of sexually transmissible infections in adolescents treated in a family planning outpatient clinic for adolescents in the western Amazon.
    PLoS One. 2023;18:e0287633.
    >> Share

  148. DUBE MANDISHORA RS, Rounge TB, Fitzpatrick M, Christiansen IK, et al
    Correction: Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping.
    PLoS One. 2023;18:e0288418.
    >> Share

  149. STRBAC M, Vukovic V, Pustahija T, Nikolic N, et al
    Motives and attitudes of parents toward HPV vaccination: Results from the initial period of HPV vaccine rollout in Serbia.
    PLoS One. 2023;18:e0287295.
    >> Share

  150. NAMBUSI K, Gbolahan A, Maureen SM, Tsholofelo RT, et al
    Youth and healthcare workers' perspectives on the feasibility and acceptability of self-testing for HIV, Hepatitis and Syphilis among young people: Qualitative findings from a pilot study in Gaborone, Botswana.
    PLoS One. 2023;18:e0288971.
    >> Share

  151. WULANDARI D, Meidyandra RW, Andrijono
    Genotype profiles of high-risk human papillomavirus in women of reproductive age: A community-based study.
    PLoS One. 2023;18:e0287399.
    >> Share

  152. ROYTRAKUL S, Sangprasert P, Jaresitthikunchai J, Phaonakrop N, et al
    Peptide barcode of multidrug-resistant strains of Neisseria gonorrhoeae isolated from patients in Thailand.
    PLoS One. 2023;18:e0289308.
    >> Share

  153. CONTRERAS NE, Roldan JS, Castillo DS
    Novel competitive enzyme-linked immunosorbent assay for the detection of the high-risk Human Papillomavirus 18 E6 oncoprotein.
    PLoS One. 2023;18:e0290088.
    >> Share

  154. HU H, Jiang H, Zhu Z, Yin H, et al
    Analysis of the anatomical distribution of HPV genotypes in head and neck squamous papillomas.
    PLoS One. 2023;18:e0290004.
    >> Share

  155. SUNGUYA B, Mboya EA, Mizinduko M, Balandya B, et al
    Epidemiology of syphilis infections among pregnant women in Tanzania: Analysis of the 2020 national representative sentinel surveillance.
    PLoS One. 2023;18:e0285069.
    >> Share

  156. ODEH HI, Al-Badi SR, Karima B, Saeed TA, et al
    Exploring the prevalence of Human Papillomavirus (HPV) genotypes in PAP smear samples of women in northern region of United Arab Emirates (UAE): HPV Direct Flow CHIP system-based pilot study.
    PLoS One. 2023;18:e0286889.
    >> Share

  157. IKEUCHI K, Fukushima K, Tanaka M, Yajima K, et al
    Changes in rapid plasma reagin titers in patients with syphilis before and after treatment: A retrospective cohort study in an HIV/AIDS referral hospital in Tokyo.
    PLoS One. 2023;18:e0292044.
    >> Share

  158. QAQISH A, Abdo N, Abbas MM, Saadeh N, et al
    Awareness and knowledge of physicians and residents on the non-sexual routes of human papilloma virus (HPV) infection and their perspectives on anti-HPV vaccination in Jordan.
    PLoS One. 2023;18:e0291643.
    >> Share

  159. IORDANISHVILI S, Metreveli T, Lipartia E, Gachechiladze K, et al
    The HPV-TP53-MALAT1 Axis: Unravelling interactions in cervical cancer development.
    PLoS One. 2023;18:e0291725.
    >> Share

  160. AYINDE O, Ross JDC, Jackson L
    Economic evaluation of antimicrobial resistance in curable sexually transmitted infections; a systematic review and a case study.
    PLoS One. 2023;18:e0292273.
    >> Share

  161. BENNETT CL, Detsky AS, Clay CE, Espinola JA, et al
    Comparison of US emergency departments by HIV priority jurisdiction designation: A case for geographically targeted screening in teaching hospitals.
    PLoS One. 2023;18:e0292869.
    >> Share

  162. GU H, Li T, Beeraka NM, Zheng Y, et al
    Molecular classification of human papilloma virus-negative head and neck squamous cell carcinomas: Cell cycle-based classifier and prognostic signature.
    PLoS One. 2023;18:e0286414.
    >> Share

  163. FEODOROVA VA, Zaitsev SS, Lyapina AM, Kichemazova NV, et al
    Whole genome sequencing characteristics of Chlamydia psittaci caprine AMK-16 strain, a promising killed whole cell veterinary vaccine candidate against chlamydia infection.
    PLoS One. 2023;18:e0293612.
    >> Share

  164. BOZICEVIC I, Blazic TN, Kosanovic Licina ML, Marijan T, et al
    Knowledge about and prevalence of Chlamydia trachomatis in a population-based sample of emerging Croatian adults.
    PLoS One. 2023;18:e0293224.
    >> Share

  165. MAHUMUD RA, Alam K, Afroz S, Ormsby GM, et al
    Correction: Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review.
    PLoS One. 2023;18:e0294379.
    >> Share

  166. PEPIOT A, Supervie V, Breban R
    Impact of voluntary testing on infectious disease epidemiology: A game theoretic approach.
    PLoS One. 2023;18:e0293968.
    >> Share

  167. ZHAO X, Gopalappa C
    Joint modeling HIV and HPV using a new hybrid agent-based network and compartmental simulation technique.
    PLoS One. 2023;18:e0288141.
    >> Share

  168. HARRYPARSAD R, Meyer B, Taku O, Serrano M, et al
    Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives.
    PLoS One. 2023;18:e0294285.
    >> Share

  169. KYEGOMBE N, Ajibola G, Sakoi-Mosetlhi M, Rebatenne T, et al
    Correction: Youth and healthcare workers' perspectives on the feasibility and acceptability of self-testing for HIV, Hepatitis and Syphilis among young people: Qualitative findings from a pilot study in Gaborone, Botswana.
    PLoS One. 2023;18:e0295779.
    >> Share

  170. QULU W, Mtshali A, Osman F, Ndlela N, et al
    High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.
    PLoS One. 2023;18:e0294698.
    >> Share

  171. LOEHRER S, Hagenbuch F, Marti H, Pesch T, et al
    Longitudinal study of Chlamydia pecorum in a healthy Swiss cattle population.
    PLoS One. 2023;18:e0292509.
    >> Share

  172. BLAYLOCK JM, Ewers EC, Bianchi EJ, King DB, et al
    Risk of sexually transmitted infections among U.S. military service members in the setting of HIV pre-exposure prophylaxis use.
    PLoS One. 2023;18:e0296054.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016